SCAI 2026 Treatment and Management of Complex Peripheral Arterial Disease-Discussion 1

Video Transcription

Video Summary

The discussion highlighted wide variation in femoropopliteal and below-knee PAD treatment strategies, with clinicians using different algorithms and devices. Panelists agreed that while new technologies are exciting, cost, hospital access, and device availability make it hard to stock everything, so providers should streamline and master a few tools. They noted some approaches, like proximal tibial scaffolding with good distal runoff, are well supported, but much remains debated. The conversation also shifted to GLP-1 agonists, with emerging evidence suggesting they may improve PAD outcomes, including limb events, walking distance, mortality, and limb loss, potentially becoming an important part of medical therapy.

Asset Caption

closed captions are computer-generated

Keywords

femoropopliteal PAD

below-knee PAD

treatment strategies

GLP-1 agonists

limb outcomes